1. 1. Walsh, N.; Beckett, G.; Chao, A.; Lo, YR. Viral hepatitis in Mongolia: situation and response. Mongolia: WPRO; 2015. Available from: http://www.wpro.who.int/hepatitis/ hepatitis_resource_publication/viral_hepatitis_mongolia_ 2015/en/publication.
2. 2. WPRO. Mongolia reached regional goal on hepatitis B control. Mongolia: WPRO; 2016. [cited 2016 Jun 3]. Available from: http://www.wpro.who.int/mongolia/mediacentre/ hepatitis_b_control/en/.
3. 3. Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou H, Zhu B, Zhao W, et al. Tenofovir to prevent hepatitis Btransmission in mothers with high viral load. N Eng J Med 2016 Jun;374:2324-2334.
4. 4. Baatarkhuu O, Uugantsetseg G, Munkh-Orshikh D, Naranzul N, Badamjav S, Tserendagva D, Amarsanaa J, Young KD. Viral hepatitis and liver diseases in Mongolia. Euroasian Journal of Hepato-Gastroenterology, January-June 2017;7(1):69-73.
5. 5. Davaalkham D, Ojima T, Uehara R, Watanabe M, Oki I, Nymadawa P, Takahashi M, Okamoto H, Nakamura Y. Hepatitis delta virus infection in Mongolia: analyses of geographic distribution, risk factors, and disease severity. Am J Trop Med Hyg 2006 Aug;75(2):365-369.